Sign in Pull a receipt

CADL

Candel Therapeutics, Inc.

Healthcare · Biotechnology

$242.42 sample

-0.11 (-0.05%) 1D

Market cap

$1.48T

Price as of

2026-10-29

Latest filing

8-K · 2026-10-27

Alerts

8

Price$242.42 -0.12% 3M daily closessample

251.71232.46

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 27SEC8-K filed: material event
Oct 20INSInsider sell: Chief Financial Officer
Oct 13INSInsider sell: Director
Oct 07INSInsider buy: EVP, Operations
Sep 30INSInsider sell: 10% owner
Sep 24INSInsider buy: Chief Financial Officer
Sep 16INSInsider sell: Chief Financial Officer
Sep 08INSInsider sell: Chief Executive Officer

Sign up to see the real CADL record →

Company facts

SEC EDGAR registration

Name: Candel Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -49sample, -100 to +100
Reporting currency: USD

Who is positioning in CADL

sample

Insiders: 6 insider transactions over 90 days, net selling, $88.3M
Congress: 2 members traded over 90 days
Institutions · 13F: 44 funds hold $9.1B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$48.3B +17.0% y/y

Q4 2024Q3 2026

Inventory$28.6B +15.3% y/y

Q4 2024Q3 2026

Accounts receivable$21.0B +14.9% y/y

Q4 2024Q3 2026

Total debt$57.7B +9.8% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $1.38T +15.7% 3M
Sample peer B: $464.9B -6.3% 3M
Sample peer C: $864.0B -3.7% 3M
Sample peer D: $273.1B -10.5% 3M
Sample peer E: $799.7B -4.8% 3M